×
Health Catalyst Net Profit Margin 2018-2024 | HCAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Health Catalyst net profit margin from 2018 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Health Catalyst Net Profit Margin 2018-2024 | HCAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Health Catalyst net profit margin from 2018 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
GE HealthCare Technologies (GEHC)
$40.4B
Tempus AI (TEM)
$7.9B
Inspire Medical Systems (INSP)
$6.2B
Axonics (AXNX)
$3.5B
Hims & Hers Health (HIMS)
$3.5B
10x Genomics (TXG)
$2.7B
Enovis (ENOV)
$2.4B
Azenta (AZTA)
$2.4B
Privia Health (PRVA)
$2.3B
IRhythm Technologies (IRTC)
$2.2B
Omnicell (OMCL)
$2B
Clover Health Investments (CLOV)
$1.5B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.4B
Standard BioTools (LAB)
$753M
Fulgent Genetics (FLGT)
$694M
Definitive Healthcare (DH)
$538M
Butterfly Network (BFLY)
$406M
Talkspace (TALK)
$343M
Pulmonx (LUNG)
$329M
SOPHiA GENETICS SA (SOPH)
$286M
TruBridge (TBRG)
$183M
P3 Health Partners (PIII)
$165M
American Well (AMWL)
$147M
Augmedix (AUGX)
$115M
EUDA Health Holdings (EUDA)
$90M
Future Health ESG (FHLT)
$65M
SHL Telemedicine (SHLT)
$55M
HeartBeam (BEAT)
$53M
111 (YI)
$51M